Think JPM seemed slow this year? You're not alone—and here's why

16th January 2020 Uncategorised 0

For many attendees, this year’s J.P. Morgan Healthcare Conference didn’t seem to live up to its trademark frenetic energy. Last year, Bristol-Myers’ $74 billion Celgene deal announcement—which happened just days before JPM—set the biopharma world abuzz, and Lilly kept the ball rolling with its $8 billion Loxo pact on Day 1 of the meeting. But this year? Crickets.

More: Think JPM seemed slow this year? You're not alone—and here's why
Source: fierce